MREO
Mereo BioPharma
MREO
MREO
80 hedge funds and large institutions have $277M invested in Mereo BioPharma in 2024 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 24 increasing their positions, 12 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
25% more funds holding
Funds holding: 64 → 80 (+16)
0.77% more ownership
Funds ownership: 11.21% → 11.98% (+0.77%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
80
Holding in Top 10
1
Calls
$2.63M
Puts
$1M
Top Buyers
| 1 | +$22M | |
| 2 | +$16.9M | |
| 3 | +$4.77M | |
| 4 |
Morgan Stanley
New York
|
+$4.06M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$3.27M |
Top Sellers
| 1 | -$23.6M | |
| 2 | -$12.3M | |
| 3 | -$4.1M | |
| 4 |
Aberdeen Group
Edinburgh,
United Kingdom
|
-$2.42M |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$1.8M |